BMY logo

Bristol-Myers Squibb (BMY) Total expenses

Annual total expenses:

$42.41B+$5.60B(+15.22%)
December 31, 2024

Summary

  • As of today (June 22, 2025), BMY annual total expenses is $42.41 billion, with the most recent change of +$5.60 billion (+15.22%) on December 31, 2024.
  • During the last 3 years, BMY annual total expenses has risen by +$4.57 billion (+12.06%).
  • BMY annual total expenses is now at all-time high.

Performance

BMY Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Quarterly total expenses:

$7.70B-$4.13B(-34.89%)
March 31, 2025

Summary

  • As of today (June 22, 2025), BMY quarterly total expenses is $7.70 billion, with the most recent change of -$4.13 billion (-34.89%) on March 31, 2025.
  • Over the past year, BMY quarterly total expenses has dropped by -$2.65 billion (-25.57%).
  • BMY quarterly total expenses is now -35.23% below its all-time high of $11.89 billion, reached on December 31, 2020.

Performance

BMY Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

BMY Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+15.2%-25.6%
3 y3 years+12.1%-14.2%
5 y5 years+109.6%-22.9%

BMY Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+15.2%-34.9%at low
5 y5-yearat high+109.6%-35.2%at low
alltimeall timeat high+596.3%-35.2%+903.1%

BMY Total expenses History

DateAnnualQuarterly
Mar 2025
-
$7.70B(-34.9%)
Dec 2024
$42.41B(+15.2%)
$11.83B(+21.7%)
Sep 2024
-
$9.72B(-7.5%)
Jun 2024
-
$10.51B(+1.5%)
Mar 2024
-
$10.35B(+8.1%)
Dec 2023
$36.81B(-0.7%)
$9.57B(+6.3%)
Sep 2023
-
$9.01B(-3.4%)
Jun 2023
-
$9.32B(+4.7%)
Mar 2023
-
$8.90B(-8.3%)
Dec 2022
$37.05B(-2.1%)
$9.71B(+6.5%)
Sep 2022
-
$9.12B(-1.4%)
Jun 2022
-
$9.24B(+3.0%)
Mar 2022
-
$8.98B(-6.9%)
Dec 2021
$37.85B(-6.2%)
$9.64B(+0.4%)
Sep 2021
-
$9.61B(+2.6%)
Jun 2021
-
$9.36B(+1.3%)
Mar 2021
-
$9.24B(-22.3%)
Dec 2020
$40.34B(+99.4%)
$11.89B(+29.3%)
Sep 2020
-
$9.20B(-0.4%)
Jun 2020
-
$9.24B(-7.6%)
Mar 2020
-
$10.00B(+35.5%)
Dec 2019
$20.23B(+16.0%)
$7.38B(+27.5%)
Sep 2019
-
$5.79B(+30.8%)
Jun 2019
-
$4.42B(+4.2%)
Mar 2019
-
$4.25B(-4.0%)
Dec 2018
$17.45B(+0.7%)
$4.42B(+10.0%)
Sep 2018
-
$4.02B(-22.2%)
Jun 2018
-
$5.17B(+36.0%)
Mar 2018
-
$3.80B(-23.4%)
Dec 2017
$17.33B(+15.8%)
$4.97B(+15.9%)
Sep 2017
-
$4.28B(-3.2%)
Jun 2017
-
$4.42B(+21.1%)
Mar 2017
-
$3.65B(-14.4%)
Dec 2016
$14.96B(+0.9%)
$4.27B(+18.4%)
Sep 2016
-
$3.61B(-3.5%)
Jun 2016
-
$3.73B(+13.9%)
Mar 2016
-
$3.28B(-25.8%)
Dec 2015
$14.83B(+4.7%)
$4.42B(+27.9%)
Sep 2015
-
$3.45B(-14.5%)
Jun 2015
-
$4.04B(+38.4%)
Mar 2015
-
$2.92B(-31.5%)
Dec 2014
$14.16B(+5.3%)
$4.26B(+32.3%)
Sep 2014
-
$3.22B(-10.4%)
Jun 2014
-
$3.59B(+15.9%)
Mar 2014
-
$3.10B(-13.4%)
Dec 2013
$13.45B(-1.7%)
$3.58B(+9.1%)
Sep 2013
-
$3.28B(-4.1%)
Jun 2013
-
$3.42B(+7.7%)
Mar 2013
-
$3.18B(-13.4%)
Dec 2012
$13.69B(-6.3%)
$3.67B(+15.4%)
Sep 2012
-
$3.18B(-7.5%)
Jun 2012
-
$3.44B(+0.8%)
Mar 2012
-
$3.41B(-12.3%)
Dec 2011
$14.61B(+7.9%)
$3.89B(+7.8%)
Sep 2011
-
$3.60B(-2.5%)
Jun 2011
-
$3.70B(+8.1%)
Mar 2011
-
$3.42B(-8.1%)
Dec 2010
$13.53B(+1.2%)
$3.72B(+15.4%)
Sep 2010
-
$3.23B(-0.9%)
Jun 2010
-
$3.26B(-2.2%)
Mar 2010
-
$3.33B(-2.5%)
Dec 2009
$13.37B(+5.3%)
$3.41B(+2.0%)
Sep 2009
-
$3.35B(+1.9%)
Jun 2009
-
$3.28B(-1.3%)
Mar 2009
-
$3.33B(+333.1%)
Dec 2008
$12.69B(-19.8%)
$768.00M(-81.0%)
Sep 2008
-
$4.04B(+3.1%)
Jun 2008
-
$3.92B(+3.0%)
Mar 2008
-
$3.81B(-25.7%)
Dec 2007
$15.82B
$5.12B(+37.5%)
Sep 2007
-
$3.72B(+2.8%)
Jun 2007
-
$3.62B(+2.5%)
DateAnnualQuarterly
Mar 2007
-
$3.53B(-1.2%)
Dec 2006
$14.87B(+0.0%)
$3.57B(-3.3%)
Sep 2006
-
$3.70B(-3.8%)
Jun 2006
-
$3.84B(+2.2%)
Mar 2006
-
$3.76B(-0.9%)
Dec 2005
$14.87B(-0.3%)
$3.79B(+0.2%)
Sep 2005
-
$3.79B(+0.6%)
Jun 2005
-
$3.77B(+6.9%)
Mar 2005
-
$3.52B(-15.3%)
Dec 2004
$14.92B(+8.7%)
$4.16B(+15.3%)
Sep 2004
-
$3.61B(-1.8%)
Jun 2004
-
$3.67B(+5.5%)
Mar 2004
-
$3.48B(+53.6%)
Dec 2003
$13.72B(-2.0%)
$2.27B(-43.0%)
Sep 2003
-
$3.98B(+2.6%)
Jun 2003
-
$3.88B(+7.7%)
Mar 2003
-
$3.60B(-12.1%)
Dec 2002
$14.01B(+9.2%)
$4.09B(+18.2%)
Sep 2002
-
$3.46B(+5.7%)
Jun 2002
-
$3.27B(+3.1%)
Mar 2002
-
$3.17B(-14.8%)
Dec 2001
$12.83B(+4.9%)
$3.73B(+24.7%)
Sep 2001
-
$2.99B(-7.5%)
Jun 2001
-
$3.23B(+5.0%)
Mar 2001
-
$3.08B(-3.1%)
Dec 2000
$12.23B(+5.1%)
$3.18B(+4.7%)
Sep 2000
-
$3.04B(-19.6%)
Jun 2000
-
$3.78B(+29.3%)
Mar 2000
-
$2.92B(-8.7%)
Dec 1999
$11.64B(+9.8%)
$3.20B(+12.4%)
Sep 1999
-
$2.85B(-20.9%)
Jun 1999
-
$3.60B(+6.6%)
Mar 1999
-
$3.38B(+235.1%)
Dec 1998
$10.61B(-13.5%)
$1.01B(-68.3%)
Sep 1998
-
$3.18B(-2.7%)
Jun 1998
-
$3.27B(+3.6%)
Mar 1998
-
$3.15B(-6.2%)
Dec 1997
$12.26B(+10.4%)
$3.36B(+13.8%)
Sep 1997
-
$2.96B(-2.5%)
Jun 1997
-
$3.03B(+4.1%)
Mar 1997
-
$2.91B(-3.2%)
Dec 1996
$11.11B(+9.5%)
$3.01B(+12.0%)
Sep 1996
-
$2.69B(-3.2%)
Jun 1996
-
$2.77B(+4.8%)
Mar 1996
-
$2.65B(-3.6%)
Dec 1995
$10.15B(+15.9%)
$2.75B(+11.8%)
Sep 1995
-
$2.46B(-5.0%)
Jun 1995
-
$2.58B(+9.0%)
Mar 1995
-
$2.37B(-5.2%)
Dec 1994
$8.76B(-2.7%)
$2.50B(+21.5%)
Sep 1994
-
$2.06B(-6.4%)
Jun 1994
-
$2.20B(+9.6%)
Mar 1994
-
$2.01B(-30.7%)
Dec 1993
$9.01B(-2.0%)
$2.90B(+42.0%)
Sep 1993
-
$2.04B(-2.8%)
Jun 1993
-
$2.10B(+6.1%)
Mar 1993
-
$1.98B(-25.6%)
Dec 1992
$9.20B(+9.6%)
$2.66B(+15.8%)
Sep 1992
-
$2.29B(+3.8%)
Jun 1992
-
$2.21B(+8.8%)
Mar 1992
-
$2.03B(-13.7%)
Dec 1991
$8.39B(+6.1%)
$2.35B(+19.3%)
Sep 1991
-
$1.97B(-3.0%)
Jun 1991
-
$2.04B(+0.2%)
Mar 1991
-
$2.03B(-10.3%)
Dec 1990
$7.91B(-2.4%)
$2.26B(+18.8%)
Sep 1990
-
$1.91B(+1.5%)
Jun 1990
-
$1.88B(+0.8%)
Mar 1990
-
$1.86B
Dec 1989
$8.11B(+19.4%)
-
Dec 1988
$6.79B(+11.4%)
-
Dec 1987
$6.09B
-

FAQ

  • What is Bristol-Myers Squibb annual total expenses?
  • What is the all time high annual total expenses for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual total expenses year-on-year change?
  • What is Bristol-Myers Squibb quarterly total expenses?
  • What is the all time high quarterly total expenses for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly total expenses year-on-year change?

What is Bristol-Myers Squibb annual total expenses?

The current annual total expenses of BMY is $42.41B

What is the all time high annual total expenses for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual total expenses is $42.41B

What is Bristol-Myers Squibb annual total expenses year-on-year change?

Over the past year, BMY annual total expenses has changed by +$5.60B (+15.22%)

What is Bristol-Myers Squibb quarterly total expenses?

The current quarterly total expenses of BMY is $7.70B

What is the all time high quarterly total expenses for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly total expenses is $11.89B

What is Bristol-Myers Squibb quarterly total expenses year-on-year change?

Over the past year, BMY quarterly total expenses has changed by -$2.65B (-25.57%)
On this page